Search research articles
Contact Us
Filters
Showing results (51-60 of 158) with videos related to
Page
of 16
Sort By:
Mutation Research
|
July 1, 1989
Induced hepatocytes as a metabolic activation system for the mouse-lymphoma assay
L A Oglesby, K H Brock, M M Moore
Mutation Research
|
June 1, 1997
Relative genotoxic potency of arsenic and its methylated metabolites
M M Moore, K Harrington-Brock, C L Doerr
Mutagenesis
|
June 22, 1999
Failure to adequately use positive control data leads to poor quality mouse lymphoma data assessments
M M Moore, D D Collard, K Harrington-Brock
Mutation Research
|
March 1, 1989
Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells
C L Doerr, K Harrington-Brock, M M Moore
Mutation Research
|
February 1, 1988
Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
M M Moore, M L Applegate, J C Hozier
Mutation Research
|
July 4, 1998
Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells
K Harrington-Brock, C L Doerr, M M Moore
Dental Update
|
February 24, 2001
Allergy to a common component of resin-bonding systems: a case report
M M Moore, F J Burke, D H Felix
The American Surgeon
|
January 1, 1997
Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial
M M Moore, D H Nguyen, W D Spotnitz
Clinical and Experimental Dermatology
|
September 13, 2014
Sebotropic eruption associated with use of oral kava kava supplement
J C Huynh, M M Asgari, M M Moore
Mutation Research
|
June 1, 1986
Genotoxicity of gamma-irradiation in L5178Y mouse lymphoma cells
M M Moore, A Amtower, G H Strauss, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 158) with videos related to
Sort By:
Page
of 16
Mutation Research
|
July 1, 1989
Induced hepatocytes as a metabolic activation system for the mouse-lymphoma assay
L A Oglesby, K H Brock, M M Moore
Mutation Research
|
June 1, 1997
Relative genotoxic potency of arsenic and its methylated metabolites
M M Moore, K Harrington-Brock, C L Doerr
Mutagenesis
|
June 22, 1999
Failure to adequately use positive control data leads to poor quality mouse lymphoma data assessments
M M Moore, D D Collard, K Harrington-Brock
Mutation Research
|
March 1, 1989
Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells
C L Doerr, K Harrington-Brock, M M Moore
Mutation Research
|
February 1, 1988
Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
M M Moore, M L Applegate, J C Hozier
Mutation Research
|
July 4, 1998
Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells
K Harrington-Brock, C L Doerr, M M Moore
Dental Update
|
February 24, 2001
Allergy to a common component of resin-bonding systems: a case report
M M Moore, F J Burke, D H Felix
The American Surgeon
|
January 1, 1997
Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial
M M Moore, D H Nguyen, W D Spotnitz
Clinical and Experimental Dermatology
|
September 13, 2014
Sebotropic eruption associated with use of oral kava kava supplement
J C Huynh, M M Asgari, M M Moore
Mutation Research
|
June 1, 1986
Genotoxicity of gamma-irradiation in L5178Y mouse lymphoma cells
M M Moore, A Amtower, G H Strauss, et al.
Page
of 16